Osteoporosis is a disease in which bones become fragile and more likely to fracture. Usually the bone loses density, which measures the amount of calcium and minerals in the bone.

Programs + Services | Doctors + Care Team | Research + Clinical Trials | News

Programs + Services

Metabolic Bone Diseases Clinic

The Metabolic Bone Diseases Clinic at Tufts Medical Center in Boston provides care to manage increased risk for fragility fractures due to bone diseases, like osteoporosis.
More information about programs and services

Bess F. Dawson-Hughes, MD

Title(s): Endocrinologist; Professor, Tufts University School of Medicine; Chief, Calcium and Bone Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Department(s): Medicine, Endocrinology, Diabetes and Metabolism
Appt. Phone: 617-556-3066
Fax #:

Metabolic bone disease, calcium and vitamin D nutrition, prevention and treatment of osteoporosis

View Full Profile for Bess F. Dawson-Hughes, MD

Lisa Ceglia, MD

Accepting New Patients

Virtual Appointments Available

Title(s): Director, Metabolic Bone Diseases Clinic; Associate Professor, Tufts University School of Medicine
Department(s): Medicine, Endocrinology, Diabetes and Metabolism
Appt. Phone: 617-636-5689
Fax #: 617-636-4719

Metabolic bone disease, nutrition, general endocrinology

View Full Profile for Lisa Ceglia, MD

Research + Clinical Trials

A Randomized, Non-Inferiority, Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women with Osteoporosis

This is a phase 3, open- label, multicenter study that will evaluate whether the Abalo patch (abaloparatide-sMTS) delivered within the layers of skin (intradermally) has a similar effect as TYMLOS^TM (abaloparatide) injection (subcutaneous, injection through the skin) when given for the treatment of osteoporosis in postmenopausal women at high risk for fractures. The study will also assess how safe the administration of Abalo patch is, to what extent individuals are able to tolerate the side effects that can possibly arise from either of the drug devices, and how they can affect day-to-day life for patients.
More information about research and clinical trials